PAIN MANAGEMENT METHODOLOGY
20220296536 · 2022-09-22
Inventors
Cpc classification
A61M2205/0238
HUMAN NECESSITIES
A61M21/00
HUMAN NECESSITIES
H04R1/1041
ELECTRICITY
A61M21/0094
HUMAN NECESSITIES
A61M21/02
HUMAN NECESSITIES
International classification
Abstract
A pain management system and methodology for preventing or alleviating chronic pain, and/or pain associated with a medical procedure prior to the medical procedure being performed, includes (a) aurally isolating a patient for a chosen period shortly prior to the patient receiving propofol in accordance with step (c), (b) exposing the patient to a repetitive, positive message during the chosen period, and (c) subsequently administering an effective quantity of propofol to the patient. For step (b), the repetitive, positive message may be delivered from a pre-recorded memory card inserted in headphones.
Claims
1. A method for preventing or ameliorating pain in a patient, the method including the steps of: (a) aurally isolating the patient for a chosen period shortly prior to the patient receiving propofol in accordance with step (c); (b) exposing the patient to a repetitive, positive message during the chosen period; and (c) subsequently administering an effective quantity of propofol to the patient.
2. The method of claim 1, wherein the step of aurally isolating the patient includes using a set of headphones on the ears of the patient.
3. The method of claim 2, wherein the message is delivered to the patient through the headphones.
4. The method of claim 1, wherein the chosen period is about 20 to 30 minutes.
5. The method of claim 1, wherein the patient is exposed to the message during all or a substantial part of the chosen period.
6. The method of claim 1, wherein the message contains substantially the following words: ‘When I wake up, I will have no pain’; or ‘When I wake up I will be pain free’; the message being repeated during the chosen period.
7. Propofol when used in a method for preventing or ameliorating pain in a patient, the method including the steps of: (a) aurally isolating the patient for a chosen period shortly prior to the patient receiving propofol in accordance with step (c); (b) exposing the patient to a repetitive, positive message during the chosen period; and (c) subsequently administering an effective quantity of propofol to the patient.
8. A set of headphones when used in the method of claim 1, wherein the message is pre-recorded on a suitable medium for playing through the headphones to the patient.
9. The set of headphones of claim 8, having a pair of headphones, each being circumaural.
10. The set of headphones of claim 8, wherein the medium is a memory card adapted for insertion in a slot in one of the headphones.
11. The set of headphones of claim 9, wherein in use a disposable interface is disposed between each headphone and the patient.
12. The set of headphones of claim 11, wherein the interface includes a soft non-woven material.
13. The set of headphones of claim 12, wherein the soft non-woven material is made of a bonded polyolefin material having spunbond and/or meltblown layers.
Description
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
[0058] The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown. In the drawings:
[0059]
[0060]
[0061]
[0062]
[0063]
[0064] It will be appreciated that the drawings are not all on the same scale.
DETAILED DESCRIPTION OF THE INVENTION
[0065] The headphones shown in each of
[0066] Referring first to
[0067] Memory card slot 18 is also located on the outside of headphone 12 (refer
[0068] Headphones 10 have a 600 MAH polymer battery which is rechargeable via a USB type charging cable plugged into a charging port (not shown) located on the outside of headphone 12.
[0069] Disposable interface 20 in
[0070] The embodiments described above relate to preferred embodiments of the present invention only and are given by way of illustration. Changes, modifications and variations may be made without departing from the spirit and scope of the present invention.
[0071] Those skilled in the art will appreciate that the invention described herein is susceptible to variations and modifications other than those specifically described. All such variations and modifications are to be considered within the scope and spirit of the present invention the nature of which is to be determined from the foregoing description.
INDUSTRIAL APPLICABILITY
[0072] Now that preferred embodiments of the present invention have been described, it will be apparent to a skilled person in the art that the method of the present invention may offer at least the following advantages: [0073] 1. Relief or elimination of post-operative pain, allowing accelerated recovery and healing as well as early discharge from hospital; [0074] 2. Avoiding post-operative pain becoming chronic pain; [0075] 3. Reduction or elimination of the need for pharmaceutical treatment of pain, reducing cost to the patient and removing danger of addiction; and [0076] 4. Enhancement of the patient's quality of life even if the patent has a terminal prognosis.